Physician profile
Megha Singh
NPI 1184252363
$529.36
in general payments reported to CMS, 2019-2025
14 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $30.64 · 2024: $304 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $529.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $94.69 | 2024-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $92.66 | 2024-2025 | Repatha, Otezla, Otezla |
| Pfizer INC. | $55.37 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $37.90 | 2024 | Airsupra |
| Glaxosmithkline, LLC. | $36.92 | 2025 | Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $36.37 | 2024-2025 | Ozempic, Rybelsus |
| Inspire Medical Systems, INC. | $30.46 | 2024 | Inspire |
| Boston Scientific Corporation | $27.65 | 2024 | Greenlight Xps |
| Phathom Pharmaceuticals, INC. | $26.00 | 2024 | Voquezna |
| Mimedx Group, INC. | $22.00 | 2024 | |
| Exact Sciences Corporation | $19.20 | 2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.13 | 2024 | Jardiance |
| Lilly USA, LLC | $17.51 | 2024 | Zepbound, Jardiance |
| Organon LLC | $14.50 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megha Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.